CARDIOGENESIS CORPORATION FROM S-8
Table of Contents

As filed with the Securities and Exchange Commission on June 13, 2002.



SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM S-8

REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933


CARDIOGENESIS CORPORATION

(Exact name of registrant as specified in its charter)


     
California
(State or Other Jurisdiction of
Incorporation or Organization)
  77-0223740
(I.R.S. Employer
Identification No.)


26632 Towne Centre Drive, Suite 320
Foothill Ranch, California 92610
(714) 649-5000
(Address, including zip code, and telephone number, including area code, of
registrant’s principal executive offices)


Stock Option Plan
Director Stock Option Plan

(Full title of the plans)


Darrell F. Eckstein
President, Chief Operating Officer and Interim Chief Financial Officer
CardioGenesis Corporation
26632 Towne Centre Drive
Suite 320
Foothill Ranch, California 92610
(714) 649-5000
(Name, address, including zip code, and telephone number, including area code, of agent for service)


With a copy to:
ROBERT K. MONTGOMERY, ESQ.
LAURENCE A. DENNY, ESQ.
Gibson, Dunn & Crutcher LLP
2029 Century Park East
Los Angeles, California 90067
(310) 552-8500


CALCULATION OF REGISTRATION FEE

                                 

            Proposed Maximum   Proposed Maximum   Amount
Title of Securities   Amount   Offering Price per   Aggregate   of Registration
to be Registered   to be Registered(1)   Share(2)   Offering Price(2)   Fee(3)

Common Stock, no par value
    1,750,000     $.89 per share   $ 1,557,500     $ 143.29  

(1)   In addition to the number of shares of Common Stock, no par value, stated above, options and other rights to purchase or acquire the shares of Common Stock under the above-referenced plans and, pursuant to Rule 416(c), an additional indeterminate number of shares which by reason of certain events specified in the Plans may become subject to the Plans.
(2)   Estimated solely for the purpose of determining the registration fee.
(3)   Calculated pursuant to Rule 457(h) based upon the average of the high and low prices of the Common Stock on the Nasdaq National Market on June 11, 2002 which was $.89.



 


TABLE OF CONTENTS

PART II
INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
ITEM 4. DESCRIPTION OF SECURITIES.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.
ITEM 8. EXHIBITS.
ITEM 9. UNDERTAKINGS.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 5.1
EXHIBIT 23.1


Table of Contents

PART II

INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT

ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.

     The following documents filed by CardioGenesis Corporation (the “Registrant”) with the Securities and Exchange Commission (the “Commission”) are incorporated by this reference and made a part of this Registration Statement:

        (a)    Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001, including Registrant’s Stock Option Plan, as amended and restated, as Exhibit 10.2 and Registrant’s Director Stock Option Plan, as amended and restated, as Exhibit 10.3;
 
        (b)    Registrant’s Quarterly Report on Form 10-Q for the quarter ending March 31, 2002;
 
        (c)    Registrant’s Definitive Proxy Statement filed with the Commission on April 26, 2002;
 
        (d)    Registration Statement No. 333-82755 on Form S-8 as filed on July 13, 1999 relating to Registrant’s Stock Option Plan, 1996 Employee Stock Purchase Plan and Director Stock Option Plan; and,
 
        (e)    The description of Registrant’s Common Stock contained in the Registrant’s Registration Statement on Form 8-A dated April 19, 1996.

     All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the date hereof, and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.

ITEM 4. DESCRIPTION OF SECURITIES.

     Not Applicable.

ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.

     Not Applicable.

ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

     Section 204 of the General Corporation Law of the State of California (“California Law”) authorizes a corporation to adopt a provision in its articles of incorporation eliminating the personal liability of directors to corporations and their shareholders for monetary damages for breach or alleged breach of directors’ “duty of care.” Following a California corporation’s adoption of such a provision, its directors are not accountable to corporations and their

 


Table of Contents

shareholders for monetary damages for conduct constituting negligence (or gross negligence) in the exercise of their fiduciary duties; however, directors continue to be subject to equitable remedies such as injunction or rescission. Under California Law, a director also continues to be liable for (1) a breach of his or her duty of loyalty; (2) acts or omissions not in good faith or involving intentional misconduct or knowing violations of law; (3) illegal payments of dividends; and (4) approval of any transaction from which a director derives an improper personal benefit. The adoption of such a provision in the articles of incorporation also does not limit directors’ liability for violations of the federal securities laws.

     Section 317 of the California Law makes a provision for the indemnification of officers, directors and other corporate agents in terms sufficiently broad to indemnify such persons, under certain circumstances, for liabilities (including reimbursement for expenses incurred) arising under the Securities Act of 1933, as amended (the “Securities Act”). An amendment to Section 317 provides that the indemnification provided by this section is not exclusive to the extent additional rights are authorized in a corporation’s articles of incorporation.

     Article IV of the Registrant’s Restated Articles of Incorporation and Article VI of the Registrant’s Amended and Restated Bylaws provide for indemnification of its directors, officers, employees and other agents to the maximum extent permitted by California Law.

ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.

     Not Applicable.

ITEM 8. EXHIBITS.

     
Exhibit    
Number   Description

 
 4.1   Stock Option Plan, as amended and restated (filed as Exhibit 10.2 to the Registrant’s Annual Report on Form 10-K, for the fiscal year ending December 31, 2001, file number 000-28288 and incorporated herein by reference).
     
 4.2   Director Stock Option Plan, as amended and restated (filed as Exhibit 10.3 to the Registrant’s Annual Report on Form 10-K, for the fiscal year ending December 31, 2001, file number 000-28288 and incorporated herein by reference).
     
 5.1   Opinion of Gibson, Dunn & Crutcher LLP
     
23.1   Consent of PricewaterhouseCoopers LLP, Independent Accountants
     
23.2   Consent of Gibson, Dunn & Crutcher LLP (included in Exhibit 5.1)
     
24.1   Power of Attorney (included on Signature Page)

 


Table of Contents

ITEM 9. UNDERTAKINGS.

     A. The undersigned Registrant hereby undertakes:

               (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

               (2) That, for the purpose of determining any liability under the Securities Act of 1933 (the “Securities Act”), each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

               (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     B. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Foothill Ranch, State of California, on the 13th day of June, 2002.

     
  CARDIOGENESIS CORPORATION
 
 
  By:  /s/ Darrell F. Eckstein
 
  Darrell F. Eckstein
President, Chief Operating Officer and
Interim Chief Financial Officer

POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael J. Quinn and Darrell F. Eckstein his true and lawful attorneys-in-fact and agents, each acting alone, with full powers of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, each acting alone, full powers and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might, or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated below.

         
Signature   Title   Date

 
 
 
/s/ Michael J. Quinn

Michael J. Quinn
  Chairman of the Board, Chief
Executive Officer and Director
(Principal Executive Officer)
  June 13, 2002
 
         
 
/s/ Darrell F. Eckstein

Darrell F. Eckstein
  President, Chief Operating Officer
and Interim Chief Financial Officer
(Principal Financial and Accounting
Officer)
  June 13, 2002
 
         
 
/s/ Jack M. Gill, Ph.D.

Jack M. Gill, Ph.D.
  Director   June 13, 2002
 
         
 
/s/ Joseph R. Kletzel II

Joseph R. Kletzel II
  Director   June 13, 2002
 
         
 
/s/ Robert L. Mortensen

Robert L. Mortensen
  Director   June 13, 2002
 
         
 
/s/ Robert C. Strauss

Robert C. Strauss
  Director   June 13, 2002

 


Table of Contents

EXHIBIT INDEX

     
Exhibit    
Number   Description

 
 4.1   Stock Option Plan, as amended and restated (filed as Exhibit 10.2 to the Registrant’s Annual Report on Form 10-K, for the fiscal year ending December 31, 2001, file number 000-28288 and incorporated herein by reference).
     
 4.2   Director Stock Option Plan, as amended and restated (filed as Exhibit 10.3 to the Registrant’s Annual Report on Form 10-K, for the fiscal year ending December 31, 2001, file number 000-28288 and incorporated herein by reference).
     
 5.1   Opinion of Gibson, Dunn & Crutcher LLP
     
23.1   Consent of PricewaterhouseCoopers LLP, Independent Accountants
     
23.2   Consent of Gibson, Dunn & Crutcher LLP (included in Exhibit 5.1)
     
24.1   Power of Attorney (included on Signature Page)